ENCOMPASS HEALTH CORPORATION

(EHC)
  Report
Delayed Nyse  -  04:00 2022-08-12 pm EDT
53.82 USD   +1.80%
08/12Mizuho Adjusts Encompass Health's Price Target to $65 from $80, Keeps Buy Rating
MT
08/08Truist Securities Adjusts Encompass Health's Price Target to $65 From $75, Maintains Buy Rating
MT
08/04ENCOMPASS HEALTH CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

ENCOMPASS HEALTH CORPORATION : Spin off

07/01/2022 EDT

A spin-Off is applied today to Encompass Health Corporation's stock price.



© Factset 2022
All news about ENCOMPASS HEALTH CORPORATION
08/12Mizuho Adjusts Encompass Health's Price Target to $65 from $80, Keeps Buy Rating
MT
08/08Truist Securities Adjusts Encompass Health's Price Target to $65 From $75, Maintains Bu..
MT
08/04ENCOMPASS HEALTH CORP Management's Discussion and Analysis of Financial Condition and ..
AQ
08/04Raymond James Adjusts Encompass Health's Price Target to $65 From $70, Reiterates Stron..
MT
08/04WALL STREET STOCK EXCHANGE : Still seeing the glass half full
MS
08/04ANALYST RECOMMENDATIONS : Illinois Tool Works, Eaton, Marathon Petroleum, Microchip Techno..
MS
08/03Barclays Lowers Encompass Health's Price Target to $63 From $80, Maintains Overweight R..
MT
08/03Credit Suisse Lowers Encompass Health's PT to $63 from $65.20; Keeps Outperform Rating
MT
08/03Deutsche Bank Adjusts Encompass Health's Price Target to $62 From $80, Maintains Buy Ra..
MT
08/03Altru Rehabilitation Hospital, a 37-bed inpatient rehabilitation hospital, now open in ..
PR
More news
Analyst Recommendations on ENCOMPASS HEALTH CORPORATION
More recommendations
Financials (USD)
Sales 2022 4 507 M - -
Net income 2022 285 M - -
Net Debt 2022 3 189 M - -
P/E ratio 2022 19,0x
Yield 2022 1,59%
Capitalization 5 370 M 5 370 M -
EV / Sales 2022 1,90x
EV / Sales 2023 1,86x
Nbr of Employees 29 294
Free-Float 85,4%
Chart ENCOMPASS HEALTH CORPORATION
Duration : Period :
Encompass Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ENCOMPASS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 13
Last Close Price 53,82 $
Average target price 64,73 $
Spread / Average Target 20,3%
EPS Revisions
Managers and Directors
Mark J. Tarr President, Chief Executive Officer & Director
Douglas E. Coltharp Chief Financial Officer & Executive Vice President
Elissa Joy Charbonneau Chief Medical Officer
Donald L. Correll Independent Director
John W. Chidsey Independent Director